Clinical Trial Update: Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents [Phase 4]

View source ↗

Summary

Phase 4 trial comparing oral sirolimus (rapamycin) with bare-metal stents versus drug-eluting stents in coronary disease; results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Restenosis

Drugs mentioned

• Rapamycin (sirolimus)

Snippet

Sponsor: Centro de estudios en Cardiologia Intervencionista | Conditions: Coronary Heart Disease, Coronary Restenosis | Phase 4 | Status: COMPLETED | Results posted: 2009-08-20